Trial Profile
Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to AMD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2021
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Dry age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Allergan
- 05 Apr 2014 New trial record
- 19 Jul 2012
- 16 Apr 2009